Jackson ImmunoResearch

Founded in 1982, Jackson ImmunoResearch specialises in producing secondary antibodies for research, diagnostics and drug discovery. With over 40 years of experience in immunoglobulin purification, conjugation and lyophilisation and a portfolio of over 3,000 original secondary antibodies, Jackson ImmunoResearch continues to develop to meet the biological demands of future advances.

Europa Biosite’s subsidiaries distribute for Jackson ImmunoResearch in Austria, Belgium, Denmark, Estonia, Finland, Iceland, Latvia, Lithuania, Luxembourg, Norway, Sweden, Switzerland and the Netherlands.